GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | BCL2 | decreases expression | EXP | | 6480464 | CTD | deoxynivalenol results in decreased expression of BCL2 mRNA deoxynivalenol results in decreased expression of BCL2 protein | PMID:25701311 PMID:29109043 | BCL2 | multiple interactions | EXP | | 6480464 | CTD | [Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein [Acetylcysteine co-treated with Zearalenone co-treated with deoxynivalenol] results in increased expression of BCL2 protein [fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA [fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA] Acetylcysteine inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein] fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein] fumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]] Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA] Zearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]] | PMID:29109043 | |
Go Back to source page | Continue to Ontology report |